Parametrica Management’s Integra LifeSciences IART Stock Holding History

Parametrica Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,352	Closed	-$215K	–	242
2022 Q1	$215K	Buy	+3,352	New	+$221K	0.16%	187
2020 Q2	–	Sell	-8,991	Closed	-$402K	–	197
2020 Q1	$402K	Buy	+8,991	New	+$472K	0.41%	52
2019 Q1	–	Sell	-7,062	Closed	-$318K	–	239
2018 Q4	$318K	Buy	+7,062	New	+$387K	0.39%	99
2016 Q3	–	Sell	-8,158	Closed	-$325K	–	183
2016 Q2	$325K	Buy	+8,158	New	+$294K	0.49%	81

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Parametrica Management's IART Position: Q2 2022 in Review

Parametrica Management sold out of Integra LifeSciences (IART) in Q2 2022, closing a stake of 3,352 shares — an estimated $215K sold.

Parametrica Management first reported a position in IART in Q2 2016 and held it in 4 quarters. The position peaked at $402K in Q1 2020. 284 funds tracked by Wall St. Rank hold IART as of Q2 2022.

Parametrica Management reported no remaining Integra LifeSciences position as of Q2 2022 after selling out during the quarter.
Parametrica Management sold 3,352 Integra LifeSciences shares in Q2 2022, an estimated $215K.
Parametrica Management first reported a position in Integra LifeSciences in Q2 2016 and held it in 4 quarters.
Parametrica Management's Integra LifeSciences position peaked at $402K in Q1 2020.
284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2022.

Based on Parametrica Management's 13F filing for Q2 2022, filed 22 Jul 2022.